|
US4307717A
(en)
|
1977-11-07 |
1981-12-29 |
Lectec Corporation |
Sterile improved bandage containing a medicament
|
|
US4704362A
(en)
|
1977-11-08 |
1987-11-03 |
Genentech, Inc. |
Recombinant cloning vehicle microbial polypeptide expression
|
|
US4352883A
(en)
|
1979-03-28 |
1982-10-05 |
Damon Corporation |
Encapsulation of biological material
|
|
JPS5754588A
(en)
|
1980-09-19 |
1982-04-01 |
Eiji Ichijima |
Alpha-mannosidase
|
|
US4353888A
(en)
|
1980-12-23 |
1982-10-12 |
Sefton Michael V |
Encapsulation of live animal cells
|
|
US4407957A
(en)
|
1981-03-13 |
1983-10-04 |
Damon Corporation |
Reversible microencapsulation of a core material
|
|
US4879231A
(en)
|
1984-10-30 |
1989-11-07 |
Phillips Petroleum Company |
Transformation of yeasts of the genus pichia
|
|
US4837148A
(en)
|
1984-10-30 |
1989-06-06 |
Phillips Petroleum Company |
Autonomous replication sequences for yeast strains of the genus pichia
|
|
US4882279A
(en)
|
1985-10-25 |
1989-11-21 |
Phillips Petroleum Company |
Site selective genomic modification of yeast of the genus pichia
|
|
US4883666A
(en)
|
1987-04-29 |
1989-11-28 |
Massachusetts Institute Of Technology |
Controlled drug delivery system for treatment of neural disorders
|
|
US4929555A
(en)
|
1987-10-19 |
1990-05-29 |
Phillips Petroleum Company |
Pichia transformation
|
|
US5158881A
(en)
|
1987-11-17 |
1992-10-27 |
Brown University Research Foundation |
Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
|
|
US5283187A
(en)
|
1987-11-17 |
1994-02-01 |
Brown University Research Foundation |
Cell culture-containing tubular capsule produced by co-extrusion
|
|
DE3829766A1
(de)
|
1988-09-01 |
1990-03-22 |
Akzo Gmbh |
Verfahren zur herstellung von membranen
|
|
DE3829752A1
(de)
|
1988-09-01 |
1990-03-22 |
Akzo Gmbh |
Integrale asymmetrische polyaethersulfonmembran, verfahren zur herstellung und verwendung zur ultrafiltration und mikrofiltration
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5084350A
(en)
|
1990-02-16 |
1992-01-28 |
The Royal Institution For The Advance Of Learning (Mcgill University) |
Method for encapsulating biologically active material including cells
|
|
US5272070A
(en)
|
1991-03-08 |
1993-12-21 |
Board Of Regents, The University Of Texas System |
Method for the preparation of cell lines producing Man3 GlcNac 2 asparagine-linked gylcans and cell lines produced thereby
|
|
SG47470A1
(en)
|
1991-04-25 |
1998-04-17 |
Univ Brown Res Found |
Implantable biocompatible immunoisolatory vehicle for delivery of a selected therapeutic products
|
|
US5968502A
(en)
|
1991-11-05 |
1999-10-19 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
|
US6042828A
(en)
|
1992-09-07 |
2000-03-28 |
Kyowa Hakko Kogyo Co., Ltd. |
Humanized antibodies to ganglioside GM2
|
|
ES2178654T3
(es)
|
1993-08-12 |
2003-01-01 |
Neurotech Sa |
Capsulas biocompatibles inmonoaisladoras que contienen celulas geneticamente alteradas para el suministro de moleculas biologicamente activas.
|
|
US5589359A
(en)
|
1994-08-05 |
1996-12-31 |
Chiron Corporation |
Chimeric proteins
|
|
US5834251A
(en)
*
|
1994-12-30 |
1998-11-10 |
Alko Group Ltd. |
Methods of modifying carbohydrate moieties
|
|
EP0922109A1
(en)
|
1996-05-21 |
1999-06-16 |
Novo Nordisk A/S |
Novel yeast promoters suitable for expression cloning in yeast and heterologous expression of proteins in yeast
|
|
US6699658B1
(en)
|
1996-05-31 |
2004-03-02 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
|
US6300065B1
(en)
|
1996-05-31 |
2001-10-09 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
|
EP0909312B1
(en)
|
1996-07-05 |
2002-12-04 |
Novo Nordisk A/S |
Method for the production of polypeptides
|
|
US6110703A
(en)
|
1996-07-05 |
2000-08-29 |
Novo Nordisk A/S |
Method for the production of polypeptides
|
|
WO1998001473A1
(en)
|
1996-07-05 |
1998-01-15 |
Novo Nordisk A/S |
Method for the production of precursors of insulin, precursors of insulin analogues, and insulin like peptides
|
|
JP2001526533A
(ja)
|
1997-04-23 |
2001-12-18 |
フラームス・インテルウニフェルシタイル・インスティチュート・フォール・ビオテヒノロヒー |
λ様プロモーターを有する遺伝子の誘導性発現のための調節系
|
|
US7442772B2
(en)
|
1997-12-03 |
2008-10-28 |
Genentech, Inc. |
Antibodies to PRO361 polypeptide
|
|
WO1999037758A2
(en)
|
1998-01-27 |
1999-07-29 |
The Board Of Regents Of The University And Community College System Of Nevada On Behalf Of The University Of Nevada-Reno |
Expression of proteolytically-sensitive peptides
|
|
WO2001042462A2
(en)
|
1999-12-08 |
2001-06-14 |
National University Of Singapore |
Phospholipase a2 inhibitory peptides from python reticulatus
|
|
US20020127219A1
(en)
|
1999-12-30 |
2002-09-12 |
Okkels Jens Sigurd |
Lysosomal enzymes and lysosomal enzyme activators
|
|
IL150314A0
(en)
|
1999-12-30 |
2002-12-01 |
Maxygen Aps |
Improved lysosomal enzymes and lysosomal enzyme activators
|
|
WO2001088143A1
(en)
|
2000-05-17 |
2001-11-22 |
Mitsubishi Pharma Corporation |
Process for producing protein with reduction of acidic sugar chain and glycoprotein produced thereby
|
|
US7863020B2
(en)
|
2000-06-28 |
2011-01-04 |
Glycofi, Inc. |
Production of sialylated N-glycans in lower eukaryotes
|
|
US8697394B2
(en)
*
|
2000-06-28 |
2014-04-15 |
Glycofi, Inc. |
Production of modified glycoproteins having multiple antennary structures
|
|
US7449308B2
(en)
|
2000-06-28 |
2008-11-11 |
Glycofi, Inc. |
Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
|
|
US7625756B2
(en)
|
2000-06-28 |
2009-12-01 |
GycoFi, Inc. |
Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
|
|
US7795002B2
(en)
*
|
2000-06-28 |
2010-09-14 |
Glycofi, Inc. |
Production of galactosylated glycoproteins in lower eukaryotes
|
|
US7598055B2
(en)
|
2000-06-28 |
2009-10-06 |
Glycofi, Inc. |
N-acetylglucosaminyltransferase III expression in lower eukaryotes
|
|
US7029872B2
(en)
|
2000-06-28 |
2006-04-18 |
Glycofi, Inc |
Methods for producing modified glycoproteins
|
|
EP2028275A3
(en)
|
2000-06-30 |
2009-05-06 |
VIB vzw |
Protein glycosylation modification in pichia pastoris
|
|
ES2258371B1
(es)
|
2000-08-31 |
2007-05-16 |
Dong Kook Pharmaceutical Co. Ltd. |
Levadura transformante productora de hormona paratiroidea humana y procedimiento para producir la hormona.
|
|
US7001994B2
(en)
|
2001-01-18 |
2006-02-21 |
Genzyme Corporation |
Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins
|
|
JP4774496B2
(ja)
|
2001-06-14 |
2011-09-14 |
独立行政法人産業技術総合研究所 |
α−マンノシダーゼ
|
|
JP4742191B2
(ja)
|
2001-06-14 |
2011-08-10 |
独立行政法人産業技術総合研究所 |
糖蛋白質およびその製造方法
|
|
US20030186374A1
(en)
|
2001-10-01 |
2003-10-02 |
Hufton Simon E. |
Multi-chain eukaryotic display vectors and uses thereof
|
|
US7473680B2
(en)
*
|
2001-11-28 |
2009-01-06 |
Neose Technologies, Inc. |
Remodeling and glycoconjugation of peptides
|
|
CA2471551C
(en)
|
2001-12-27 |
2014-09-30 |
Glycofi, Inc. |
Methods to engineer mammalian-type carbohydrate structures
|
|
ES2327830T3
(es)
|
2002-03-29 |
2009-11-04 |
Schering Corporation |
Anticuerpos monoclonales humanos anti-interleuquina-5 y metodos y composiciones que los contienen.
|
|
JP4464269B2
(ja)
|
2002-04-26 |
2010-05-19 |
協和発酵キリン株式会社 |
哺乳類型糖鎖生産メチロトロフ酵母
|
|
US7252933B2
(en)
*
|
2002-06-26 |
2007-08-07 |
Flanders Interuniversity Institute For Biotechnology |
Protein glycosylation modification in methylotrophic yeast
|
|
EP1534835B1
(en)
|
2002-06-29 |
2010-09-08 |
Korea Research Institute of Bioscience and Biotechnology |
Hansenula polymorpha yapsin deficient mutant strain and process for the preparation of recombinant proteins using the same
|
|
KR100470978B1
(ko)
|
2003-01-02 |
2005-03-10 |
한국생명공학연구원 |
앱신 다중 결손 효모 변이 균주 및 이를 이용한 재조합 단백질의 생산 방법
|
|
AU2012206984B2
(en)
|
2003-02-11 |
2015-07-09 |
Takeda Pharmaceutical Company Limited |
Diagnosis and treatment of multiple sulfatase deficiency and other using a formylglycine generating enzyme (FGE)
|
|
JP4259169B2
(ja)
|
2003-04-16 |
2009-04-30 |
昭和産業株式会社 |
新規α−1,2−マンノシダーゼおよびその遺伝子、ならびに該酵素を用いたα−マンノシル糖化合物の製造方法
|
|
US7259255B2
(en)
|
2003-06-25 |
2007-08-21 |
E. I. Du Pont De Nemours And Company |
Glyceraldehyde-3-phosphate dehydrogenase and phosphoglycerate mutase promoters for gene expression in oleaginous yeast
|
|
EP1696864B1
(en)
|
2003-12-24 |
2014-11-12 |
GlycoFi, Inc. |
Methods for eliminating mannosylphosphorylation of glycans in the production of glycoproteins
|
|
DE602005020745D1
(de)
|
2004-02-10 |
2010-06-02 |
Zystor Therapeutics Inc |
Saure alpha-glukosidase und fragmente davon
|
|
WO2005089047A2
(en)
|
2004-03-18 |
2005-09-29 |
Glycofi, Inc. |
Glycosylated glucocerebrosidase expression in fungal hosts
|
|
JP2007535317A
(ja)
*
|
2004-04-15 |
2007-12-06 |
グライコフィ, インコーポレイテッド |
下等真核生物におけるガラクトシル化された糖タンパク質の産生
|
|
JP4954866B2
(ja)
|
2004-04-29 |
2012-06-20 |
グライコフィ, インコーポレイテッド |
糖タンパク質の作製においてアルファ−マンノシダーゼ抵抗性グリカンを減少させるか又は排除する方法
|
|
CA2501422C
(en)
|
2004-04-29 |
2014-08-12 |
University Of Rochester |
Lymphoid chemokines in the diagnosis, monitoring and treatment of autoimmune disease
|
|
US20060014264A1
(en)
|
2004-07-13 |
2006-01-19 |
Stowers Institute For Medical Research |
Cre/lox system with lox sites having an extended spacer region
|
|
US7431927B2
(en)
|
2005-03-24 |
2008-10-07 |
Epitomics, Inc. |
TNFα-neutralizing antibodies
|
|
WO2007010403A2
(en)
|
2005-04-14 |
2007-01-25 |
Scir |
Recombinant yeasts for synthesizing epoxide hydrolases
|
|
US8202523B2
(en)
|
2005-09-22 |
2012-06-19 |
ProSci, Inc. |
Glycosylated polypeptides produced in yeast mutants and methods of use thereof
|
|
US20080081035A1
(en)
|
2006-10-03 |
2008-04-03 |
National Enzyme Company |
Therapeutic protease compositions
|
|
EP2068914A4
(en)
|
2007-02-09 |
2011-07-20 |
Medimmune Llc |
PRESENTATION OF ANTIBODY BANK BY PLASMA MEMBRANES OF YEAST CELLS
|
|
JP5967861B2
(ja)
|
2007-04-03 |
2016-08-10 |
オキシレイン ユーケー リミテッド |
分子のグリコシル化
|
|
US8569032B2
(en)
|
2007-05-18 |
2013-10-29 |
Tokyo Metropolitan Institute Of Medical Science |
Proteins having acquired A-galactosidase activity
|
|
EP2189014B1
(en)
*
|
2007-09-14 |
2014-06-25 |
Unwired Planet International Limited |
User data notification in a mobile communications system
|
|
PL3219795T3
(pl)
|
2008-01-18 |
2024-09-16 |
Biomarin Pharmaceutical Inc. |
Wytwarzanie aktywnych wysoce fosforylowanych ludzkich enzymów sulfatazy lizosomalnej i ich zastosowania
|
|
JP2011514157A
(ja)
*
|
2008-02-20 |
2011-05-06 |
グライコフィ, インコーポレイテッド |
蛋白質生産用ベクター及び酵母株
|
|
WO2009137721A2
(en)
|
2008-05-07 |
2009-11-12 |
Zystor Therapeutics, Inc. |
Lysosomal targeting peptides and uses thereof
|
|
JP2012518999A
(ja)
|
2009-02-26 |
2012-08-23 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー |
宿主細胞およびその使用方法
|
|
KR102000383B1
(ko)
|
2009-09-29 |
2019-07-15 |
유니버시테이트 젠트 |
만노스-1-포스포-6-만노스 결합의 포스포-6-만노스로의 가수분해
|
|
US20130053550A1
(en)
|
2009-11-19 |
2013-02-28 |
Oxyrane Uk Limited |
Yeast strains producing mammalian-like complex n-glycans
|
|
FR2954349A1
(fr)
|
2009-12-22 |
2011-06-24 |
Agronomique Inst Nat Rech |
Sulfatase modifiant selectivement les glycosaminoglycanes
|
|
US20130096281A1
(en)
|
2010-01-21 |
2013-04-18 |
Oxyrane Uk Limited |
Methods and compositions for displaying a polypeptide on a yeast cell surface
|
|
US20120135461A1
(en)
|
2010-07-30 |
2012-05-31 |
William James Cook |
Production of glycoproteins with reduced o-glycosylation comprising the use of an alpha-1,2-mannosidase
|
|
JP6131190B2
(ja)
|
2010-09-29 |
2017-05-17 |
オキシレイン ユーケー リミテッド |
リン酸化n−グリカンの脱マンノシル化
|
|
BR112013007616B1
(pt)
|
2010-09-29 |
2023-01-24 |
Oxyrane Uk Limited |
Métodos para retirar o cap ("uncapping") de porções de manose-1- fosfo-6-manose e desmanosilar n-glicanos fosforilados em uma glicoproteína, para direcionar uma glicoproteína para o interior de uma célula de mamífero, e para converter uma glicoproteína de uma primeira forma que não se liga substancialmente a um receptor de manose-6-fosfato em uma segunda forma que se liga substancialmente a um receptor de manose-6-fosfato em uma célula de mamífero
|
|
JP2015503338A
(ja)
|
2011-12-30 |
2015-02-02 |
オキシレイン ユーケー リミテッド |
組換えタンパク質の分解を低減させる方法および材料
|
|
CA2867237C
(en)
|
2012-03-15 |
2024-01-02 |
Wouter Vervecken |
Methods and materials for treatment of pompe's disease
|
|
US20190040368A1
(en)
|
2013-03-05 |
2019-02-07 |
Oxyrane Uk Limited |
Production of catalytically active type i sulfatase
|